Cargando…

Therapeutic Approaches to the Neurologic Manifestations of COVID-19

As of May 2022, there have been more than 527 million infections with severe acute respiratory disease coronavirus type 2 (SARS-CoV-2) and over 6.2 million deaths from Coronavirus Disease 2019 (COVID-19) worldwide. COVID-19 is a multisystem illness with important neurologic consequences that impact...

Descripción completa

Detalles Bibliográficos
Autores principales:	Graham, Edith L., Koralnik, Igor J., Liotta, Eric M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Current Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302225/ https://www.ncbi.nlm.nih.gov/pubmed/35861926 http://dx.doi.org/10.1007/s13311-022-01267-y

Ejemplares similares

Frequent neurologic manifestations and encephalopathy‐associated morbidity in Covid‐19 patients
por: Liotta, Eric M., et al.
Publicado: (2020)

Lifting the mask on neurological manifestations of COVID-19
por: Pezzini, Alessandro, et al.
Publicado: (2020)

Evolution of neurologic symptoms in non‐hospitalized COVID‐19 “long haulers”
por: Ali, Sareen T., et al.
Publicado: (2022)

Animal models to study the neurological manifestations of the post-COVID-19 condition
por: Usai, Carla, et al.
Publicado: (2023)

Transforming Drug Development for Neurological Disorders: Proceedings from a Multidisease Area Workshop
por: Stephenson, Diane, et al.
Publicado: (2023)

Machine Learning in Clinical Trials: A Primer with Applications to Neurology
por: Miller, Matthew I., et al.
Publicado: (2023)

Neurological manifestations of COVID-19: A perspective from Pakistani medical students
por: Adil, Mariam, et al.
Publicado: (2022)

Reply to COVID‐19 encephalopathy, Bayes rule, and a plea for case–control studies
por: Liotta, Eric M., et al.
Publicado: (2021)

Persistent neurologic symptoms and cognitive dysfunction in non‐hospitalized Covid‐19 “long haulers”
por: Graham, Edith L., et al.
Publicado: (2021)

Clinical time course of COVID-19, its neurological manifestation and some thoughts on its management
por: Zhou, Yifan, et al.
Publicado: (2020)

Update on Intravenous Immunoglobulin in Neurology: Modulating Neuro-autoimmunity, Evolving Factors on Efficacy and Dosing and Challenges on Stopping Chronic IVIg Therapy
por: Dalakas, Marinos C.
Publicado: (2021)

COVID-19, palliative care and public health
por: Rodin, Gary, et al.
Publicado: (2020)

ADHD as a Risk Factor for Infection With Covid-19
por: Merzon, Eugene, et al.
Publicado: (2020)

Longitudinal Associations Between COVID-19 Stress and the Mental Health of Children With ADHD
por: Summerton, Ainsley, et al.
Publicado: (2023)

Maskne: A New Acne Variant in Covid-19 Era
por: Rathi, Sanjay K., et al.
Publicado: (2022)

T cell responses to SARS-CoV-2 in people with and without neurologic symptoms of long COVID
por: Visvabharathy, Lavanya, et al.
Publicado: (2022)

Impact of COVID-19 and suspension of colorectal cancer screening on incidence and stage distribution of colorectal cancers in the Netherlands
por: Toes-Zoutendijk, Esther, et al.
Publicado: (2022)

Potential Risks and Benefits of Multiple Sclerosis Immune Therapies in the COVID-19 Era: Clinical and Immunological Perspectives
por: Bhise, Vikram, et al.
Publicado: (2021)

Study of the SARS-CoV-2-specific immune T-cell responses in COVID-19-positive cancer patients
por: Mansi, Laura, et al.
Publicado: (2021)

Coronavirus disease (COVID-19) outbreak and phase 1 trials: should we consider a specific patient management?
por: Postel-Vinay, Sophie, et al.
Publicado: (2020)

Immune checkpoint inhibitors: a physiology-driven approach to the treatment of coronavirus disease 2019
por: Di Cosimo, Serena, et al.
Publicado: (2020)

Neurological, neuropsychiatric and neurodevelopmental complications of COVID-19
por: Pantelis, Christos, et al.
Publicado: (2020)

MicroRNA Mimics or Inhibitors as Antiviral Therapeutic Approaches Against COVID-19
por: Hum, Christine, et al.
Publicado: (2021)

Neurological manifestations of COVID-19 – an approach to categories of pathology
por: Leven, Yana, et al.
Publicado: (2021)

COVID-19: Ocular Manifestations and the APAO Prevention Guidelines for Ophthalmic Practices
por: Wong, Raymond L.M., et al.
Publicado: (2020)

Neurological Dysfunction in Long COVID Should Not Be Labelled as Functional Neurological Disorder
por: Van der Feltz-Cornelis, Christina M., et al.
Publicado: (2023)

SIOG COVID-19 working group recommendations on COVID-19 therapeutic approaches in older adults with cancer
por: Russo, Chiara, et al.
Publicado: (2023)

GM-CSF-based treatments in COVID-19: reconciling opposing therapeutic approaches
por: Lang, Frederick M., et al.
Publicado: (2020)

Role of proteolytic enzymes in the COVID-19 infection and promising therapeutic approaches
por: Gioia, Magda, et al.
Publicado: (2020)

Exosomes in neurological disease, neuroprotection, repair and therapeutics: problems and perspectives
por: Kalani, Anuradha, et al.
Publicado: (2015)

Acute-care hospital reencounters in COVID-19 patients
por: Clark, Jeffrey R., et al.
Publicado: (2021)

Comedication and Polypharmacy With ADHD Medications in Adults: A Swedish Nationwide Study
por: Zhang, Le, et al.
Publicado: (2020)

National Institutes of Health Blueprint Neurotherapeutics Network: Results to Date and Path Forward
por: Cywin, Charles L., et al.
Publicado: (2017)

COVID-19 and Neurological Manifestations
por: Forero, Kathleen, et al.
Publicado: (2023)

Exploring the Longitudinal Relationship Between Short Sleep Duration, Temperament and Attention Deficit Hyperactivity Disorder Symptoms in a Biethnic Population of Children Aged Between 6 and 61 Months: A Born in Bradford Study
por: Stott, Jonathan, et al.
Publicado: (2023)

Pharmacotherapy of ADHD in Adults With Autism Spectrum Disorder: Effectiveness and Side Effects
por: Muit, J. J., et al.
Publicado: (2019)

Alpha-synuclein Immunization Strategies for Synucleinopathies in Clinical Studies: A Biological Perspective
por: Knecht, Luisa, et al.
Publicado: (2022)

Attention Deficit Hyperactivity Disorder in Children and Adults: A Population Survey on Public Beliefs
por: Speerforck, Sven, et al.
Publicado: (2019)

Efficacy and Safety of Dasotraline in Children With ADHD: A Laboratory Classroom Study
por: Wigal, Sharon B., et al.
Publicado: (2019)

Deep Brain Stimulation for Addictive Disorders—Where Are We Now?
por: Yuen, Jason, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_shfgq92f88io7d4bi84b9v8mqs